AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2020

Nov 19, 2020

Director's Dealing

Opens in your device viewer

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-11-17

Reporting Person: TERRELL JASON BRADLEY MD (Chief Medical Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-17	Common Stock	S	1571	$3.4	Disposed	58378	Direct
2020-11-18	Common Stock	S	3229	$3.35	Disposed	55149	Direct
2020-11-18	Common Stock	S	200	$3.45	Disposed	54949	Direct